Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Mairs

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Biology|August 3, 2000
Absence of delayed chromosomal instability in a normal human fibroblast cell line after 125I iododeoxyuridineC S Griffin, A Neshasateh-Riz, R J Mairs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatmentA Livingstone, R J Mairs, J Russell, et al.
British Journal of Haematology|August 1, 1986
Progesterone inhibits proliferation of human marrow colony forming cells (CFU-GM) through increased prostaglandin production by marrow macrophagesM A Smith, N P Lucie, M M Ferguson, et al.
British Journal of Cancer|June 9, 1999
Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parentsF Rinaldi, R J Mairs, T E Wheldon, et al.
British Journal of Cancer|January 1, 1997
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emittersA Neshasteh-Riz, W J Angerson, J R Reeves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1995
No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparationR J Mairs, S H Cunningham, J Russell, et al.
Dose-Response : a Publication of International Hormesis Society|March 25, 2014
Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effectsM D Gow, C B Seymour, M Boyd, et al.
British Journal of Cancer|March 1, 1991
The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroidsR J Mairs, W Angerson, M N Gaze, et al.
The British Journal of Radiology|October 10, 2008
Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combinationA G McCluskey, M Boyd, S L Pimlott, et al.
British Journal of Cancer|July 2, 1998
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissionsS H Cunningham, R J Mairs, T E Wheldon, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Biology|August 3, 2000
Absence of delayed chromosomal instability in a normal human fibroblast cell line after 125I iododeoxyuridineC S Griffin, A Neshasateh-Riz, R J Mairs, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatmentA Livingstone, R J Mairs, J Russell, et al.
British Journal of Haematology|August 1, 1986
Progesterone inhibits proliferation of human marrow colony forming cells (CFU-GM) through increased prostaglandin production by marrow macrophagesM A Smith, N P Lucie, M M Ferguson, et al.
British Journal of Cancer|June 9, 1999
Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parentsF Rinaldi, R J Mairs, T E Wheldon, et al.
British Journal of Cancer|January 1, 1997
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emittersA Neshasteh-Riz, W J Angerson, J R Reeves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1995
No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparationR J Mairs, S H Cunningham, J Russell, et al.
Dose-Response : a Publication of International Hormesis Society|March 25, 2014
Dose calculations for [(131)i] meta-iodobenzylguanidine-induced bystander effectsM D Gow, C B Seymour, M Boyd, et al.
British Journal of Cancer|March 1, 1991
The distribution of alternative agents for targeted radiotherapy within human neuroblastoma spheroidsR J Mairs, W Angerson, M N Gaze, et al.
The British Journal of Radiology|October 10, 2008
Experimental treatment of neuroblastoma using [131I]meta-iodobenzylguanidine and topotecan in combinationA G McCluskey, M Boyd, S L Pimlott, et al.
British Journal of Cancer|July 2, 1998
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissionsS H Cunningham, R J Mairs, T E Wheldon, et al.
Pageof 5